Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Fenbufen
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fenbufen 300mg capsules
1001010F0AAAAAA
|
Fenbufen | Fenbufen | Musculoskeletal and Joint Diseases | No data available |
|
Fenbufen 300mg tablets
1001010F0AAABAB
|
Fenbufen | Fenbufen | Musculoskeletal and Joint Diseases | No data available |
|
Fenbufen 450mg tablets
1001010F0AAACAC
|
Fenbufen | Fenbufen | Musculoskeletal and Joint Diseases | No data available |
|
Lederfen 300mg capsules
1001010F0BBAAAA
|
Lederfen | Fenbufen | Musculoskeletal and Joint Diseases | No data available |
|
Lederfen 300mg tablets
1001010F0BBABAB
|
Lederfen | Fenbufen | Musculoskeletal and Joint Diseases | No data available |
|
Lederfen 450mg tablets
1001010F0BBADAC
|
Lederfen | Fenbufen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.